| Views | |
|---|---|
| Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing | 222 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing | 28 | 6 | 2 | 18 | 5 | 21 | 12 |
| Views | |
|---|---|
| 2021_Jurmeister_etal.pdf | 107 |
